The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture
Abstract
Toxicity of 6‐hydroxydopamine (6‐OHDA) and dopamine were studied in cultures of dissociated fetal rat mesencephalic cells. To assess survival and function of dopaminergic cells we quantified the number of tyrosine hydroxylase‐positive cells and measured dopamine uptake. Non‐dopaminergic cells were monitored by counting the number of cells visible with phase‐contrast microscopy and measuring GABA uptake. 6‐OHDA, in contrast to MPP +, which selectively destroyed dopaminergic neurons, was found to be a non‐selective neurotoxin in this culture system. Between 10 and 100 μM, dopaminergic and non‐dopaminergic cells were destroyed. At concentrations frequently used to lesion catecholaminergic neurons in vivo, 6‐OHDA resulted in structural fixation and loss of viability of dopaminergic and non‐dopaminergic cells. Dopamine produced the same actions at slightly higher concentrations. One hundred to 300 μM was toxic for all cell types, and concentrations above 300 μM resulted in fixation. The findings suggest that 6‐OHDA cannot be considered a selective toxin for catecholaminergic neurons in vitro. The demonstrated toxicity of dopamine tends to support speculations that processes related to dopamine metabolism may play a role in the pathogenesis of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emson, P., Heffher, R. R., & Pearson, J. (1984) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198409000-00010 · Cited by 1,648
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
Chiba, K., Trevor, A., & Castagnoli, N. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91293-2 · Cited by 1,097
Cohen, G., Heikkila, R. E., & MacNamee, W. T. T. A. O. D. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42751-8 · Cited by 897
Pharmacological Actions of 6-Hydroxydopamine
Kostrzewa, R. M., & Jacobowitz, D. M. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06677-3 · Cited by 817
Catecholamines: Basic and Clinical Frontiers
(1979) · Elsevier eBooks · doi:10.1016/c2013-1-15197-0 · Cited by 728
EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAIN
Uretsky, N. J., & Iversen, L. L. (1970) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1970.tb02210.x · Cited by 653
6-Hydroxydopamine and catecholamine neurons
Malmfors, T., Thoenen, H., & Co, F. H.-L. R. (1971) · North-Holland eBooks · Cited by 634
Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine
BREESE, G. R., & TRAYLOR, T. D. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb07089.x · Cited by 527
Specht, L. A., Pickel, V. M., Joh, T. H., & Reis, D. J. (1981) · Journal of Comparative Neurology · doi:10.1002/cne.901990208 · Cited by 497
Breese, G. R., & Traylor, D. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xd59-xs65 · Cited by 487
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454
COYLE, J. T., & SNYDER, S. H. (1969) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28416-6 · Cited by 453
Tranzer, J. P., & Thoenen, H. (1968) · Experientia · doi:10.1007/bf02146956 · Cited by 442
Specht, L. A., Pickel, V. M., Joh, T. H., & Reis, D. J. (1981) · Journal of Comparative Neurology · doi:10.1002/cne.901990207 · Cited by 353
Monoamine Innervation of the Cerebral Cortex
Krystal, J. H. (1985) · PubMed Central · Cited by 307
The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence.
Cohen, G. (1983) · PubMed · Cited by 226
Possible role of neuromelanin in the pathogenesis of Parkinson's disease
MANN, D., & YATES, P. (1983) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(83)90074-x · Cited by 211
Catecholamine toxicity in cerebral cortex in dissociated cell culture
Rosenberg, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02887.1988 · Cited by 208
BREESE, G. R., & TRAYLOR, T. D. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07257.x · Cited by 207
Quantitation of Fluorescence of Biogenic Monoamines
Jonsson, G. (1971) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(71)80001-3 · Cited by 183
Model Experiments on the Molecular Mechanism of Action of 6-Hydroxydopamine
SANER, A., & THOENEN, H. (1971) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12658-8 · Cited by 182
Kalyanaraman, B., Premović, P. I., & Sealy, R. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60929-9 · Cited by 155
POIRIER, L. J., Langelier, P., Roberge, A. G., Boucher, R., & Kitsikis, A. (1972) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(72)90047-0 · Cited by 149
Breese, G. R., & Traylor, T. D. (1970) · PubMed · Cited by 127
Serum Factor Supporting Long-Rerm Survival of Rat Central Neurons in Culture
Kaufman, L. M., & Barrett, J. N. (1983) · Science · doi:10.1126/science.6857258 · Cited by 113
Sanchez‐Ramos, J., Michel, P. P., Weiner, W. J., & Hefti, F. F. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02500.x · Cited by 86
Self-citationLICHTENSTEIGER, W. (1970) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(70)80010-9 · Cited by 55
Cited by
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Oxidative damage in the central nervous system: protection by melatonin
Reiter, R. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00052-5 · Cited by 838
Metadata
- Authors
- Michel, P. P., & Hefti, F.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1990-08
- Volume
- 26
- Issue
- 4
- Pages
- 428-435
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2105551817
- Cited by
- 338
- References
- 30
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.